IHH Healthcare Bhd.
In the news
- IHH Healthcare dragged down by goodwill impairment Jun 29, 2020
- Bangkok virtual hospital finds opportunity in lockdown Jun 6, 2020
- Singapore health tech mClinica to raise $20m as coronavirus spurs growth May 1, 2020
- Asian stocks rebound as central banks pledge support to fight virus impact Mar 2, 2020
- Asia businesses brace for virus amid China New Year exodus Jan 22, 2020 See more articles on IHH Healthcare Bhd.
Company Background
IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.
Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.
IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.
IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.
Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.
Business Summary
Financial Highlights
| Dec 2020 | MYR | USD |
| Revenue | 13,404.60M | 3,189.89M |
| Gross Profit | 2,709.70M | 644.82M |
| Operating income | 914.38M | 217.59M |
| Income before tax | 549.11M | 130.67M |
| Net income | 199.03M | 47.36M |
| EBITDA | 2,311.70M | 550.11M |
| Diluted EPS | 0.02 | 0.00 |
| Dividends Per Share | 0.04 | 0.00 |
| Total Assets | 44,746.72M | 11,124.10M |
| Total liabilities | 19,869.41M | 4,939.56M |
| Total equity | 21,739.81M | 5,404.55M |
| Operating cash flow | 2,085.16M | 496.20M |
| Currency in MYR | Currency in USD |
Historical Data
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | |
| Revenue | 10,021.88M | 11,142.63M | 11,520.93M | 14,912.48M | 13,404.60M |
| Gross Profit | 2,657.91M | 2,620.19M | 2,884.52M | 3,677.11M | 2,709.70M |
| Operating income | 1,227.74M | 1,068.88M | 1,203.24M | 1,685.73M | 914.38M |
| Income before tax | 860.94M | 1,162.33M | 739.05M | 968.61M | 549.11M |
| Net income | 612.35M | 931.31M | 541.84M | 463.30M | 199.03M |
| EBITDA | 2,026.87M | 2,046.96M | 2,142.40M | 3,041.22M | 2,311.70M |
| Diluted EPS | 0.07 | 0.11 | 0.06 | 0.05 | 0.02 |
| Dividends Per Share | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| Total Assets | 37,200.39M | 38,925.48M | 45,020.85M | 45,111.62M | 44,746.72M |
| Total liabilities | 13,307.23M | 15,183.41M | 18,827.09M | 19,175.82M | 19,869.41M |
| Total equity | 21,985.74M | 21,890.16M | 21,994.00M | 22,339.53M | 21,739.81M |
| Operating cash flow | 1,730.45M | 2,006.03M | 1,562.71M | 2,595.44M | 2,085.16M |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | |
| Revenue | 2,419.15M | 2,591.60M | 2,854.98M | 3,599.45M | 3,189.89M |
| Gross Profit | 641.58M | 609.41M | 714.80M | 887.55M | 644.82M |
| Operating income | 296.36M | 248.60M | 298.17M | 406.88M | 217.59M |
| Income before tax | 207.82M | 270.34M | 183.14M | 233.79M | 130.67M |
| Net income | 147.81M | 216.60M | 134.27M | 111.82M | 47.36M |
| EBITDA | 489.26M | 476.09M | 530.90M | 734.06M | 550.11M |
| Diluted EPS | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 |
| Dividends Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 8,292.55M | 9,618.35M | 10,894.33M | 11,028.38M | 11,124.10M |
| Total liabilities | 2,966.39M | 3,751.77M | 4,555.86M | 4,687.89M | 4,939.56M |
| Total equity | 4,900.96M | 5,408.98M | 5,322.20M | 5,461.32M | 5,404.55M |
| Operating cash flow | 417.70M | 466.57M | 387.25M | 626.46M | 496.20M |
Valuation Measures
| Dec 2020 | |
| PER | 242.29 |
| ROA | 0.44% |
| ROE | 0.90% |
| Operating margin | 6.82% |
| Profit margin | 1.48% |
Key executives
- CEO, MD & Non-Independent Executive Director: Chi-Keon Loh
- Group Chief Operating Officer: Heng Joo Sim
- Group Chief Financial Officer: Joerg Ayrle
- Group Head-Internal Audit: Stephen Byrne
- Vice President-Investor Relations: Penelope Koh
Shareholders
- Mitsui & Co., Ltd. (32.9%)
- Khazanah Nasional Bhd. (Investment Company) (26.0%)
- Employees Provident Fund (9.3%)
- Permodalan Nasional Bhd. (5.1%)
- AYDINLAR MEHMET ALI (4.8%)
- Kumpulan Wang Persaraan (3.0%)
- Public Mutual Bhd. (1.7%)
- Kuwait Investment Authority (Investment Management) (1.6%)
- AYDINLAR FAMILY (1.1%)
- The Vanguard Group, Inc. (1.0%)
Contact Details
- Website:http://www.ihhhealthcare.com
- Address: Pantai Hospital Kuala Lumpur, 8 Jalan Bukit Pantai, Kuala Lumpur, 59100, Malaysia
- Phone: +60.3.2298.9898
Related Companies
- Northern TK Venture Pte Ltd.
- IHH Healthcare Bhd. (Singapore)
- Centre For Digestive & Kidney Diseases India Pvt Ltd.
- Acibadem Saglik Yatirimlari Holding AS
- Indah Capital Ltd.
- Shanghai Mai Kang Hospital Investment Management Co. Ltd.
- Bodrum Tedavi Hizmetleri A.S
- Integrated Healthcare Turkey Yatirimlari Ltd.
- Gleneagles Development Pte Ltd.
- Integrated Healthcare Holdings Ltd.
- Acibadem Saglik Hizmetleri ve Ticaret AS
- Pantai Holdings Sdn. Bhd.
- Parkway Holdings Ltd.
Competitors
- New Frontier Health Corp.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 30 Jul, 2021
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.